CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Resolution (S.Con.Res.14)/Budget Reconciliation (H.R.5376).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical IP and supply chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Advance the use of and access to FDA-approved medications to treat addiction and mental illness in criminal justice and public health settings; pharmaceutical supply chain issues; drug pricing. Implementation of Comprehensive Addiction and Recovery Act of 2016 (P.L.114-198), 21st Century Cures Act (P.L.114-255), SUPPORT for Patients and Communities Act (P.L.115-271), and CARES Act (P.L.116-136). S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings, including SAMHSA funding; FY2022 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (H.R.4355/S.2604); FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); FY2022 Department of the Interior, Environment, and Related Agencies Appropriations Act (H.R.4372); H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2022 Consolidated Appropriations Act (H.R.4502).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.